DeepMind Spinout Claims AI Agent Beats OpenAI, Anthropic at Research Replication

Google DeepMind, Meta, and Isomorphic Labs are jointly investing $300 million into Biohub, Mark Zuckerberg and Priscilla Chan's nonprofit biomedical research organization. The funding supports a $1.8 billion initiative to build AI datasets enabling researchers to simulate biological systems digitally. Biohub, founded in 2016, aims to develop a 'virtual cell' that could accelerate disease prevention and management research.

OpenAI released 722 manuscripts containing solutions to hundreds of long-standing mathematics problems generated by an unreleased frontier model. The batch covers 372 result families and was coordinated through AGMAI, an independent advisory group of elite mathematicians formed to handle responsible communication of the findings. The release extends OpenAI's recent run of mathematical breakthroughs while raising ongoing questions about research ethics and academic conduct in AI-driven discovery.

A MIT Technology Review Insights report based on a survey of 300 technology executives finds that enterprise AI agents fail to reach production at scale due to insufficient organizational knowledge and fragmented data systems. Only about one-third of agentic AI projects make it to production across most organizations, while a small group of production leaders advance 61% of their projects by maintaining stronger knowledge capabilities. The research identifies legacy data systems, security concerns, and lack of contextual understanding as key barriers, with knowledge graphs and retrieval-augmented generation emerging as priority investments to close the gap.

Researchers at the Weizmann Institute of Science have developed an AI tool that reconstructs images from brain scans with notable accuracy by analyzing fMRI data. The system works bidirectionally, predicting both what a person sees from their brain activity and their brain response to visual stimuli. While developers see therapeutic potential for locked-in patients and dream analysis, neuroscientists warn the technology could enable non-consensual extraction of thoughts and mental imagery.